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ABSTRACT
Introduction: Obesity is a growing epidemic fuelled
by unhealthy behaviours and associated with
significant comorbidities and financial costs. While
behavioural interventions produce clinically meaningful
weight loss, weight loss maintenance is challenging.
This may partially be due to failure to target stress and
emotional reactivity. Mindfulness-based stress
reduction (MBSR) reduces stress and emotional
reactivity and may be a useful tool for behaviour
change maintenance. This study seeks to provide a
mechanistic understanding for clinical trials of the
benefits of MBSR for weight loss maintenance by
examining changes in functional connectivity (FC) and
the association of these changes with clinical
outcomes.
Methods and analysis: Community-dwelling
individuals (n=80) who intentionally lost ≥5% of their
body weight in the past year will be recruited and
randomised to an MBSR programme or educational
control. FC using resting-state functional MRI will be
measured at baseline and 8 weeks. Psychological
factors, health behaviours, body mass index and waist
circumference will be measured at baseline, 8 weeks
and 6 months post intervention. A 12-month telephone
follow-up will assess self-reported weight. Analyses
will characterise FC changes in response to MBSR in
comparison with a control condition, assess the
relationship between baseline FC status and pre–post
MBSR changes in FC and investigate the association of
FC change with changes in psychological factors and
weight loss maintenance.
Ethics and dissemination: The University of
Massachusetts Medical School Institutional Review
Board has approved this study, Declaration of Helsinki
protocols are being followed, and patients will give
written informed consent. The Independent Monitoring
Committee will monitor protocol adherence.
Results from the study will be disseminated to
the medical community at conferences and submitted
for publication in peer-reviewed journals when the
last patient included has been followed up for
12 months.
Trial registration number: NCT02189187.
INTRODUCTION
Unhealthy behaviours such as overeating and
sedentary lifestyles are major contributors to
cardiovascular disease, cancer, type 2 dia-
betes and other chronic conditions. They
have produced a rapid rise in obesity that
threatens to reverse recent gains in life
expectancy1 and accounts for a large per-
centage of premature deaths in the USA.2
The number of obese adults in the USA is
expected to rise by 65 million from 2010 to
2030, resulting in a predicted additional 6–8
million cases of diabetes, 5–6.8 million cases
of heart disease and stroke, and over 400 000
cancer cases.3 For each 5 kg/m2 increase in
Body Mass Index (BMI), the risks of
oesophageal cancer and colon cancer in
men increase by 52% and 24%, respectively,
and the risks of endometrial cancer, gall
bladder cancer, and breast cancer in women
increase by 59%, 59% and 12%, respectively.4
In addition to signiﬁcant morbidity, obesity
has a substantial ﬁnancial impact due to
Strengths and limitations of this study
▪ This is a timely and innovative study that will
advance the field of mindfulness research and
increase understanding of its mechanisms of
action, setting the stage for a comprehensive
clinical trial.
▪ The intervention is low-risk, highly accessible,
low-cost and is implemented in a real-world clin-
ical population and community setting. The
control course was specifically designed to serve
as an attention control for mindfulness-based
stress reduction.
▪ The cost of a neuroimaging biomarker could be
considered a limitation for large-scale clinical
trials, but the insights about neural mechanisms
of change cannot be obtained with other
methods.
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healthcare costs and decreased productivity.
Obesity-related US healthcare costs were $2.5 trillion in
2009 and are predicted to rise by at least $22 billion/
year by 2020 and $48 billion/year by 2030.3
Weight loss is vital for reducing these extensive health
and economic burdens, and even minimal weight loss
has a meaningful impact. In an overweight and obese
population in Ireland, a 1 kg/m2 decrease in BMI led to
26 fewer cases of chronic disease per 1000 men and 28
fewer cases per 1000 women.5 Similarly, a 1% decrease
in BMI across the US population (1 kg weight loss for
the average adult) is predicted to prevent 2.1–2.4
million cases of diabetes, 1.4–1.7 million cases of cardio-
vascular disease, and 73 000–127 000 cancer cases; and
would only require reducing caloric intake by 20 kcal/
day for 3 years.3
Current obesity treatments include lifestyle modiﬁca-
tion, pharmacotherapy and surgical options. A systematic
review of various approaches to weight loss maintenance
found that behavioural interventions involving food
intake and physical activity led to signiﬁcant, albeit
small, improvements in weight loss maintenance at
12 months after the intervention.6 Exercise programmes
alone, however, may be most effective in the adoption
phase.7 Similarly, certain medications such as orlistat
and sibutramine facilitate weight loss but commonly only
work short term when used alone, and may have
unfavourable side effects.8 Bariatric surgery can be
effective long term, but it can be associated with peri-
operative surgical risks and weight regain is common.8
Also, many patients are unwilling or ineligible to
undergo surgery.
Many interventions are effective for initiating weight
loss and other health behaviour changes, but they have
shown only limited ability to affect signiﬁcant, long-term
behaviour change in the majority of adults.7 9–11 In part,
this may be attributable to a failure of existing interven-
tions to adequately address the effects of stress and emo-
tional reactivity on relapse to unhealthy behaviours and
failure to maintain long-term behaviour change.
Perceived stress and symptoms of emotional reactivity
(depression, anxiety, anger) are linked to unhealthy life-
style behaviours12–15 and predict worse outcomes in
maintenance studies.16–18 Indeed, studies of health
behaviour change have demonstrated that perceived
stress19–21 and indices of emotional reactivity such as
anxiety,22–24 depression and anger25–27 are associated
with poor outcomes. In contrast, positive affect is asso-
ciated with improved outcomes.28 29
Mindfulness, deﬁned as paying attention to one’s
inner and outer experiences in a non-judgmental
manner from moment to moment,30 has been asso-
ciated with healthy behaviours. Dispositional mindful-
ness in obese patients awaiting bariatric surgery was
found to be positively associated with a restrained eating
style (using restrictive control over food to lose weight)
but negatively associated with emotional (eating in
response to emotional states) and external eating
behaviours (eating in response to external cues).
Mindfulness may discourage external eating by increas-
ing sensitivity to hunger and satiety such that these
internal cues guide behaviour instead. In addition,
mindfulness may prevent emotional eating by encour-
aging acceptance of negative feelings, lowering stress
and thus promoting distinction between emotion and
hunger. Finally, mindfulness has been shown to decrease
impulsivity which may reduce unhealthy eating
behaviours.31
Several mindfulness-based or mindfulness-associated
practices are promising agents of behaviour change, but
we need to understand their neural mechanisms in
order to optimise their use. Mindfulness-based stress
reduction (MBSR) is a psycho-educational programme
that teaches emotional and physical self-care.
Participants receive training in formal and informal
mindfulness practices and learn about the role of good
nutrition, rest and exercise, as well as the role played by
thoughts and emotions in physical and emotional
health. They are taught how to cultivate a non-reactive
awareness of mental and physical experience in an
effort to increase self-efﬁcacy and reduced emotional
reactivity—leading to healthier lifestyle practices. A
recent comparative effectiveness review found moder-
ately strong evidence for mindfulness meditation pro-
grammes, particularly MBSR, for anxiety, depression and
pain compared with non-speciﬁc active controls, and
weaker evidence for stress and health-related quality of
life.32 Evidence is mixed regarding the effectiveness of
mindfulness-based interventions on weight loss, at least
with relatively short follow-up periods.33 Whether MBSR
can support maintenance of weight loss following suc-
cessful initiation of health behaviour change warrants
investigation based on its ability to lower emotional and
behavioural reactivity to stress and negative emotions,
risk factors for relapse to unhealthy behaviours.
Importantly, an understanding of neural targets and
mechanisms of change is necessary for specifying for
whom mindfulness is likely to work and for optimising
the intervention for maximal effectiveness. Mindfulness
may work better in speciﬁc subpopulations, as seen in a
group of women with speciﬁc endogenous opioidergic
activity who were found to be more receptive to mindful-
ness training in an effort to decrease pleasure eating.34
Additionally, efﬁcacy of mindfulness-based therapy has
been strongly positively associated with dispositional
mindfulness of participants and therapists.35
Neuroimaging, speciﬁcally resting-state functional MRI
(fMRI), is a powerful approach to identifying mechan-
isms of change for MBSR involving the role of emotion
regulation in maintenance of health behaviour change.
Neuroimaging studies report an association between
MBSR and changes in functional connectivity (FC) that
may reﬂect improved attention, sensory processing and
reﬂective awareness of sensory experience.36 37
Mindfulness has also been shown to alter resting-state
FC of the amygdala, a region involved in physiological
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stress response. A randomised controlled trial (RCT)
found that a 3-day intensive mindfulness training
reversed the effects of stress on the amygdala–subgenual
anterior cingulate cortex in a group of stressed
unemployed adults in the community.38 This mindful-
ness training was also shown to increase resting-state FC
between the default mode network and the left dorsolat-
eral prefrontal cortex, an area involved in top-down
executive control.39 However, no previous studies have
examined how mindfulness training affects the neural
circuitry of emotion regulation in a weight loss sample
and little is known about mechanisms of behaviour
change in people undergoing mindfulness training.
Gaps in knowledge
Emerging evidence suggests that mindfulness may be
helpful for changing behaviours such as overeating40 but
the mechanistic knowledge of how mindfulness facili-
tates behaviour change is not known. Efforts to ﬁll this
gap could enhance our ability to identify likely ‘respon-
ders’ and thus optimise intervention efforts, consistent
with current trends towards personalised medicine
approaches. Speciﬁcally, we are lacking knowledge of
speciﬁc neural targets of mindfulness training to inform
clinical trials of health behaviour change and mainten-
ance of change. In addition, data on long-term out-
comes of mindfulness training are lacking.
Understanding the neural mechanisms that link MBSR
to changes in emotional regulation and behaviour are a
critical next step in tapping the potential of MBSR as an
intervention for behaviour change and maintenance. A
validated biomarker will allow investigators to monitor
ﬁdelity of intervention delivery, adherence and dose–
response in clinical trials. If validated as a biomarker,
changes in FC will allow future studies to determine
characteristics of individuals who are most responsive to
MBSR and which components of the mindfulness inter-
vention are most active, and may enable development of
a more compact and potent intervention. FC may also
help identify subsets of high-risk patients that would
beneﬁt from speciﬁc tailoring of the intervention. It is
worth noting that if clinical trials prove that MBSR pre-
vents weight regain, MRIs would not be required in a
larger dissemination study or as the intervention is
deployed in a large-scale public health approach.
Study aims and hypotheses
To characterise FC, psychological, behavioural and
anthropometric changes in response to MBSR and the
comparison condition, we will randomise a sample of 80
participants who have intentionally lost ≥5% of their body
weight during the previous year to MBSR or an attention
control speciﬁcally designed to be structurally equivalent
to MBSR. Study aims and hypotheses are as follows.
Our ﬁrst primary aim is to characterise FC changes in
response to MBSR and the comparison condition. We
hypothesise that participants randomised to the MBSR
condition will experience greater increases in FC from
baseline to post intervention (Hypothesis 1), and partici-
pants with higher baseline FC will show less change in
response to MBSR (Hypothesis 2).
Our second primary aim is to investigate the associ-
ation of FC change with changes in psychological factors
and maintenance of weight loss at 8 weeks and 6-month
follow-up. We hypothesise that increases in FC will be
associated with improvement in depressive symptoms
(Hypothesis 3) and inversely related to decreased weight
(BMI) and total waist circumference (Hypothesis 4).
Our third primary aim is to assess changes in BMI at 6
and 12 months to obtain preliminary measures of effect size and
variability by study group for future clinical trials.
As secondary aims, we will use mediation analysis to
determine how change in FC is explained by (1) class
attendance, (2) self-reported time in homework prac-
tice, (3) self-reported time for each speciﬁc component
of the multifaceted training programme and (4) trait
mindfulness. An exploratory aim is to examine correla-
tions of change in FC with changes in additional psycho-
logical factors (perceived stress, trait anger, trait anxiety,
positive affect) and health behaviours (healthy eating,
physical activity, sleep quality).
METHODS
Study design
The ‘Keeping Weight Off’ study is a randomised, pro-
spective, two-armed, controlled trial. A sample of 80 par-
ticipants from the community, who have intentionally
lost at least 5% of their body weight during the previous
year, will be equally randomised into two groups: an
MBSR programme and a healthy living course (HLC)—
an attention control speciﬁcally designed to be structur-
ally equivalent to MBSR.41 The HLC uses the same
format of 8-weekly classes lasting 2.5 hours, and controls
for attention and other non-speciﬁc factors including
staff interactions, psychoeducation about health and
stress management, classroom format, homework, group
process and data collection.41 Our main outcome mea-
sures are resting-state FC, depression symptoms, BMI
and waist circumference. FC, psychological factors,
health behaviours, BMI and waist circumference will be
measured at baseline and 8 weeks. Psychological factors,
health behaviours, BMI and waist circumference will also
be measured at 6 months. In addition, a telephone
follow-up will be attempted on participants at 12 months
to assess weight.
Total planned enrolment is 80 participants. Screening
for eligibility criteria, baseline visits and follow-up visits
will take place at University of Massachusetts Medical
School (UMMS), Worcester, Massachusetts. All MBSR
classes will be conducted at the UMMS Center for
Mindfulness in Shrewsbury, Massachusetts.
Study participants
We will recruit participants who range in age from 25 to
60 (chosen to minimise age-related changes in FC),
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have intentionally lost ≥5% of their body weight during
the previous year and are motivated to maintain this
weight loss. Individuals will be excluded if they have par-
ticipated in an MBSR course, regular meditation prac-
tice or any other form of meditative practice (such as
yoga, Tai Chi or contemplative prayer), for more than
an average of 20 min per week within the past 2 years.
Full inclusion and exclusion criteria are listed in table 1.
Eligible participants will proceed with the baseline visit
prior to randomisation, including collection of demo-
graphic information about age, education, marital status,
occupation and current employment status, followed by
questionnaires and fMRI scan. The full study schedule of
recruitment, treatment and assessments is described in
table 2. All participants will provide informed consent.
This process will be conducted by the study coordinator
in person prior to the baseline visit, following the proto-
col established by the University of Massachusetts
Institutional Review Board (IRB). Study staff will keep in
touch with participants regarding attendance and home-
work completion and provide support and encourage-
ment to continue with the intervention if participants
express dissatisfaction. Participants who drop out of the
intervention will be asked to return for all follow-up visits
to complete all outcome data collection.
Study recruitment
Recruitment will be conducted using advertising in the
community (internet, ﬂyers and social media) of
Worcester County, which has a population of over 800 000,
as well as a two-stage process to recruit outpatients from
the UMass Memorial Medical Center using the electronic
medical record. The largest healthcare system in Central
and Western Massachusetts, the medical centre has a large
population from which to draw, with nearly 70 000 patient
visits for primary care alone, and a Weight Center that
sees nearly 1000 new patients per year. Our team has an
excellent record of recruitment and retention in our pre-
vious overweight/obese subjects using these methods.
First, with a Health Insurance Portability and
Accountability Act (HIPAA) waiver authorisation a
search query will be conducted with basic eligibility cri-
teria, and second, identiﬁed records will be reviewed to
exclude causes of weight loss such as serious illness or
weight loss medications. Web-based and telephone
screening will determine whether they meet inclusion
criteria. Further screening will be done in person to
gather a medical history and complete the Structured
Clinical Interview for DSM-IV (SCID) to exclude partici-
pants with a serious psychiatric, cognitive or medical dis-
order or a history of alcohol or substance abuse or
dependence in the past 6 months.
Randomisation and study blinding
Study participants will be equally randomised to either the
MBSR intervention arm or HLC arm based on a permuted
blocks randomisation scheme. In this procedure, treat-
ment allocations will be made within blocks so that the
numbers assigned to each arm are equal after each block
has been ﬁlled. Blocks of various sizes (2, 4, 6) will be used
Table 1 Eligibility criteria
Inclusion criteria: Exclusion criteria:
▸ Men and women
▸ Right or left handed
▸ Ages 25–60
▸ Intentionally lost ≥5% of body weight during the
previous year
▸ Intending to maintain weight loss
▸ BMI >25 kg/m2 in the past 2 years and greater than
20.5 kg/m2 at time of study entry
▸ Under the care of a primary care physician for at least
the last year prior to screening
▸ Able to communicate by telephone with research staff
▸ Have a healthcare provider, personal trainer or
weight-loss counsellor who can complete and sign a
form indicating the amount and timing of their weight
loss OR have a dated photograph
▸ or weight loss diary71
▸ Weight >300 lbs (limitation of MRI scanner)
▸ Prior participation in an MBSR course
▸ Regular meditation practice (or any other form of meditative
practice, such as yoga, Tai Chi, or contemplative prayer) for
more than an average of 20 min/week within the past 2 years
▸ Serious psychiatric, cognitive or medical disorder
▸ Alcohol/substance abuse or dependence in past 6 months
▸ Any conditions that are incompatible with MRI
▸ Structural brain damage as determined by an independent
neuroradiologist, based on T1W 3D TFE sagittal and T1W
FFE axial images
▸ History of an eating disorder, diabetes mellitus or
medications for diabetes mellitus
▸ Medication that affects weight (weight loss medications,
corticosteroids, antipsychotics)
▸ History of weight loss surgery
▸ Participation in another weight management research study
▸ Regain of >3% of total body weight in the 2 months prior to
study entry
▸ Childbirth in the past 6 months
▸ Claustrophobia, or any MRI incompatible implants
▸ Pregnant or planning to become pregnant
▸ Unable to consent
3D, three dimensional; BMI, Body Mass Index; FFE, Turbo Flash Field Echo; MBSR, mindfulness-based stress reduction; T1W, T1 weighted;
TFE, Turbo Field Echo.
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in random order, to facilitate allocation concealment, that
is, to make it nearly impossible to determine the treatment
assignment based on a pattern of previous treatment allo-
cations. Randomisation will be implemented using sealed
envelopes by the study coordinator who will be the only
member of the research team who is not blind to treat-
ment assignment. A unique identiﬁcation number will
help to ensure that blindness is maintained throughout
the study. All members of the research team involved in
data analysis will be blind to treatment assignment.
To address the possibility that an imbalanced distribu-
tion of baseline FC could mask important ﬁndings, we
will employ a non-stratiﬁed permuted-block randomised
design with an interim analysis of the distribution of
baseline FC. If important imbalances are found, we will
implement recruitment strategies to increase enrolment
of participants who have baseline FC with a speciﬁed
range combined with covariate-adaptive randomisation
techniques. Residual imbalances will be addressed with
post hoc statistical adjustment.
Assessments
Resting-state FC
In contrast to task-evoked functional and effective con-
nectivity studies, resting-state fMRI enables examination
of the brain’s intrinsic functional connections in the
absence of externally controlled stimuli or tasks.42 43 FC
is responsive to changing levels of stress,44 intense train-
ing on a task45 and recently, meditation practice includ-
ing MBSR.46 47 FC has been shown to have remarkable
consistency and moderate-to-high test–test reliability over
periods of months to a year as well.48 49 All MRIs will be
acquired on the 3T scanner (Philips Achieva) in the
UMMS Advanced MRI Center. Three-dimensional high-
resolution structural T1-weighted MR images will be
obtained to provide anatomical landmarks. Following
the structural imaging, resting-state fMRI data will be col-
lected. Participants will be instructed to remain relaxed
with eyes closed as fMRI images are continuously col-
lected for 10 min. The duration of the entire MRI pro-
cedure will be 30 min.
Table 2 Study schedule of recruitment, treatment and assessments as a function of time points (according to the SPIRIT
2013 figure guidelines)
Duration of the study
Recruitment Baseline
Post-treatment
(8 weeks)
Follow-up
(6 months)
Follow-up
(12 months)
TIME POINT t0 t1 t2 t3 t4
RECRUITMENT
Screening for inclusion/exclusion
criteria
X
Informed consent X
Assignment to treatment arms X
TREATMENT
MBSR X X
HLC X X
ASSESSMENT
SCID-IV X
fMRI X X
Weight X X X X
Height (and BMI) X X X
Waist circumference X X X
CES-D X X X
PSS-14 X X X
STAI-T X X X
STAXI-II X X X
Satisfaction with life X X X
Emotion Regulation
Questionnaire
X X X
Eating Behaviour Inventory X X X
Internal Disinhibition Subscale of
the Eating Inventory
X X X
Paffenbarger Physical Activity
Scale
X X X
Pittsburgh Sleep Quality Index X X X
CES-D, Center for Epidemiologic Studies Depression Scale; HLC, healthy living course; MBSR, mindfulness-based stress reduction; PSS-14,
Perceived Stress Scale; SCID-IV, Structured Clinical Interview for DSM-IV; SPIRIT, Standard Protocol Items: Recommendations for
Interventional Trials; STAI-T, State-Trait Anxiety Inventory—trait version; STAXI-II, State-Trait Anger Expression Inventory-II.
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Psychological symptoms
The Center for Epidemiologic Studies Depression Scale
(CES-D)50 depression symptom score is a primary
outcome. Additional outcomes include perceived stress,
anxiety, anger, positive affect and emotion regulation,
which will be assessed using the following measures,
respectively: the Perceived Stress Scale (PSS-14),51 the
State-Trait Anxiety Inventory—trait version (STAI-T),52
the State-Trait Anger Expression Inventory-II (STAXI-II)
trait anger subscale,53 the Satisfaction with Life Scale54
and the Emotion Regulation Questionnaire.55
Health behaviours
Health behaviours will be assessed using the Eating
Behaviour Inventory,56 the Internal Disinhibition
Subscale of the Eating Inventory,57 the Paffenbarger
Physical Activity Scale58 and the Pittsburgh Sleep Quality
Index (PSQI),59 respectively.
Anthropometrics
Procedures are adapted from the Centers for Disease
Control (CDC)’s Anthropometry Procedures Manual.60
For the measurement of height and weight, the Seca
213 Portable stadiometer and the tanita, BWB-800 elec-
tronic scale will be used and measurements will be taken
twice and averaged to assure reliability. Measurement of
waist circumference will be taken directly on the skin
using measuring tape placed just above top of the iliac
crest on each side.
Potential mediators and confounders
Intervention engagement will be assessed with class
attendance and a home practice log. Treatment expect-
ancy and credibility will be assessed with the Credibility/
Expectancy Questionnaire (CEQ)61 modiﬁed slightly to
substitute the word ‘Class’ for ‘Therapy’ in the instruc-
tions. Secondary analyses will examine how change in
FC is explained by (1) class attendance, (2) self-reported
time in homework practice, (3) self-reported time for
each speciﬁc component of the multifaceted training
programme and (4) trait mindfulness as measured by
the Five Facet Mindfulness Questionnaire (FFMQ).62
Interventions
Experimental condition: MBSR
MBSR, described above, is taught in eight weekly classes
and one all-day retreat. Homework assignments include
formal meditation practices and informal practices
during daily life. Classroom activities teach formal medi-
tation practices including sitting meditation, body scan,
mindful yoga and walking meditation. Participants also
learn to bring awareness in the present moment to
aspects of daily life and apply this practice to stressful
experiences in order to avoid reﬂexive or conditioned
reactions. The goal of MBSR is to provide participants
with these skills for lifelong self-management.
The MBSR classes are taught by certiﬁed teachers
from the UMass Center for Mindfulness. All teachers
have completed the rigorous training and certiﬁcation
for MBSR through the Center for Mindfulness. To
further assure ﬁdelity, each class will be reviewed in
weekly sessions with a coinvestigator. In addition, the
principal investigators will routinely convene the entire
clinical research team to monitor the overall ﬁdelity of
the MBSR intervention.
Attention control: HLC
The HLC was speciﬁcally designed to serve as a control
condition for MBSR.41 HLC consists of eight weekly
2-hour classes. Sessions consist of lectures and discussion
on the following topics: healthy living, healthy eating,
physical activity and health, sleep and health, stress man-
agement, time management and unhealthy behaviours
(smoking, drinking). The HLC is designed to control
for attention and other non-speciﬁc factors including
staff interactions, psychoeducation about health and
stress management, classroom format, homework, group
process and data collection.41
Data collection
Electronic data capture (EDC, Research Electronic Data
Capture (REDCap)) will be used for all data collection
except imaging. Surveys for psychological symptoms, health
behaviours and potential mediators and confounders are
programmed into the EDC system. During research visits,
participants will enter survey responses directly into this
system and research staff will enter screening and anthropo-
metric data with periodic checks for quality assurance. All
data will be maintained in a secure location accessible only
to study personnel. For MRI measures, data will be analysed
blind to intervention group by two fMRI experts who
perform cross-validity checks.
Data analysis and sample size considerations
We based the study sample size on Hypothesis 1, powered
to detect an effect size of 0.32 SDs. This moderate Cohen
effect size63 represents differential overtime change for
the intervention versus comparison group cast in SD
units. The study design calls for a baseline measurement
and two follow-up measurements. In addition, we
assumed a two-tailed α error of 0.05, and a within-person
correlation for overtime measurement of 0.8.64 With
these assumptions, 40 participants in each group are
needed for 80% power. We will enrol 100 participants (50
randomised to each arm) and allow for up to 20% loss to
follow-up, for an effective sample size of 80.
Statistical analysis will begin with univariate summaries
of data distributions and examination of longitudinal
trends with graphic displays. Bivariate associations will
then be examined using the χ2 test, analysis of variance
(ANOVA), and the Spearman correlation test.
Hypotheses 1 and 2 focus on overtime differences
between the two study groups, while Hypotheses 2 and 3
focus on overtime differences for the combined sample.
Hypotheses will be formally tested using generalised
linear mixed models that represent the clustering of
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observations within participants as a random intercept,
adopt an appropriate link and distribution for the spe-
ciﬁc outcome and parameterise the intervention effect as
a group-time intervention, when appropriate.65 To pre-
serve the power of randomisation, hypothesis testing will
be performed on an intent-to-treat basis. As a secondary
aim, mediation analysis will determine how change in FC
is explained by markers of intervention adherence using
techniques as described by MacKinnon.66 67 Sensitivity
analyses with multiple imputation with chained equations
will address missing data.
Imaging data is preprocessed using Statistical Parametric
Mapping (SPM8) software (Wellcome Department of
Cognitive Neurology, London, UK) running under the
MATLAB environment (Mathworks, Sherborn,
Massachusetts, USA). The data are initially corrected for
motion (threshold of 2 mm). Further preprocessing of the
data includes (1) slice scan time correction, (2) spatial
smoothing using a three-dimensional Gaussian ﬁlter
(4-mm full width at half maximum (FWHM)) and (3)
voxel-wise linear detrending and 0.01–0.08 Hz band-pass
ﬁltering. Structural and functional data of each participant
are then be transformed to standard stereotaxic space68 to
facilitate group analysis.
Following the preprocessing steps, FC will be gener-
ated using correlational analysis. Left and right amygda-
lae are used as separate seed regions of interest (ROI).
FC maps from each individual seed will then be calcu-
lated for each individual subject using Resting-State
fMRI Data Analysis Toolkit (REST, http://www.restfmri.
net). Each seed ROI will be evaluated using two-way
repeated measures ANOVA on a voxel-by-voxel basis
(factors: group and imaging day) at the threshold of
p<0.05 after accounting for multiple comparisons using
the criteria of false discovery rate (FDR).69 Voxels with
signiﬁcantly changed FC within each ROI will then be
averaged to generate the FC change for the ROI. This
procedure will yield a single value of
amygdala-orbitofrontal FC for each participant at each
point in time. All ROI deﬁnitions are based on
Automated Anatomical Labelling (AAL)70 built in the
MARSeille Boîte À Région (MarsBAR) toolbox of SPM8.
Image analysis will be done blind to group membership.
As a secondary analysis, we will explore FC changes in
other brain networks following MBSR using other seed
regions. For example, other cortical regions that have
been implicated in modulation of limbic reactivity (eg,
anterior cingulate) will be examined using a hypothesis-
driven approach.
Ethical considerations and dissemination plans
This study is registered as a national clinical trial
(NCT02189187) and Declaration of Helsinki protocols
are being followed, and patients will give written
informed consent. Protocol adherence will be moni-
tored by the Independent Monitoring Committee (for
full WHO Trial Registration Data Set information see
online supplementary appendix). Results from the study
will be disseminated to the medical community at con-
ferences and submitted for publication in peer-reviewed
journals when the last patient included has been fol-
lowed up for 12 months. Negative and inconclusive as
well as positive results will be published or made publicly
available through the study website http://www.
umassmed.edu/keepingweightoff.
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